Handelsbanken Fonder
DYN icon

Handelsbanken Fonder’s Dyne Therapeutics DYN Stock Holding History

Handelsbanken Fonder’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+53,200
New +$989K ﹤0.01% 1055
2025
Q2 		– Sell
-22,500
Closed -$235K – 1527
2025
Q1 		$235K Hold
22,500
– – ﹤0.01% 1467
2024
Q4 		$530K Buy
22,500
+3,200
+17% +$94.7K ﹤0.01% 1261
2024
Q3 		$693K Buy
19,300
+3,400
+21% +$135K ﹤0.01% 1098
2024
Q2 		$561K Buy
+15,900
New +$462K ﹤0.01% 1108

Other funds holding DYN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
AP
Aspect Partners Fairfax, Virginia $268M AUM 22.57% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Handelsbanken Fonder's DYN Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 53,200 shares worth $1.18M. The stake represents ﹤0.01% of the portfolio and ranks #1055 among its holdings. This is a return to the name: Handelsbanken Fonder previously reported a position in DYN as recently as Q1 2025.

Handelsbanken Fonder first reported a position in DYN in Q2 2024 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Handelsbanken Fonder held 53,200 shares of Dyne Therapeutics worth $1.18M as of Q2 2026.
  • Dyne Therapeutics was a new Handelsbanken Fonder position in Q2 2026.
  • Dyne Therapeutics made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1055 holding.
  • Handelsbanken Fonder first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.